ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

Schilskly Promoted to Associate Dean At Chicago, Vogelzang To Direct Center

March 5, 1999

Trials Approved by NCI CTEP For the Month of April

April 27, 2012

Hammer Blast GAO Report As ”Gobblygook”

June 12, 1987

Barbara Rimer Named NCAB Chairman; First Women Appointed To Lead Board

September 16, 1994

Rogers Eyes Saccharin Ban

March 18, 1977